In this webinar, you will hear from the team at LifeStrands Genomics Australia about their newly launched Benchmark 659, a NGS panel powered by Twist’s target enrichment technology. Twist’s target enrichment technology supports cancer research by identifying biomarkers for disease detection and characterisation.

You will learn the science behind the panel, real-world applications, and how Twist can support clinical researchers for cancer research. Whether you’re a treating clinician, molecular pathologist or scientist, or healthcare leader, this session will demonstrate how advanced genomics can be accessible, actionable, and centred around improving patient care.